RxSight, Inc. (RXST)
RXSTNASDAQ-GMOphthalmic Goods
$4.91
+0.0500 (+1.03%) today
Regular session, Nov 10, 1:34 PM ET
- Market cap
- $205.87m
- P/E
- –
- EPS, last 4 quarters
- $-1.28
- Dividend yield
- –
- Day range
- $4.74 to $5.12
- 52-week range
- $4.11 to $13.22
- Average volume
- 819.8k
- Previous close
- $4.86
Analysts
7 coveringUnderperform0 buy, 6 hold, 1 sell
Targets a year out average $6.19, +26.1% from here
Earnings
next estimate $0.1000Next report
Dec 2025
+46.3%
Mar 2026
-26.7%
Jun 2026
+21.6%
Sep 2026
+7.1%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $32.61m | $30.89m | $33.74m | $24.59m |
| Gross profit | $25.26m | $23.50m | $25.89m | $18.10m |
| Operating income | -$11.34m | -$17.83m | -$13.77m | -$18.52m |
| Net income | -$9.15m | -$15.88m | -$12.10m | -$16.23m |
Last four quarters: revenue $121.83m, margin -43.8%, free cash flow $18.64m
News
8 latest- RxSight (RXST) Q3 2026 Earnings Call TranscriptThe Motley Fool · 6 days ago
- RxSight Q3 Net Loss Widens To $16.2 Mln As Revenue Falls 19%; Stock Down RTTNews · 6 days ago
- What RxSight (RXST) Said on Its Q3 Earnings CallMarketBeat · 7 days ago
- RxSight, Inc. Reports Third Quarter 2026 Financial ResultsFintel · 7 days ago
- RxSight, Inc. (RXST) Reports Q3 Loss, Lags Revenue EstimatesZacks · 7 days ago
- RxSight (RXST) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 12, 2026
- RxSight Q2 Earnings Call HighlightsMarketBeat · Aug 6, 2026
- UFP Technologies (UFPT) Beats Q2 Earnings and Revenue EstimatesZacks · Aug 3, 2026
The company
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens products (LAL and LAL+), RxSight Light Delivery Device (LDD), and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery.
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- rxsight.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.